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Deubiquitinating enzymes (DUBs) play an important role in regulating a variety of
eukaryotic processes. In this context, exploring the role of deubiquitination in Leishmania
infantum could be a promising alternative to search new therapeutic targets for
leishmaniasis. Here we present the first characterization of a DUB from L. infantum,
otubain (OtuLi), and its localization within parasite. The recombinant OtuLi (rOtuLi)
showed improved activity on lysine 48 (K48)-linked over K63-linked tetra-ubiquitin (Ub)
and site-directed mutations on amino acids close to the catalytic site (F82) or involved
in Ub interaction (L265 and F182) caused structural changes as shown by molecular
dynamics, resulting in a reduction or loss of enzyme activity, respectively. Furthermore,
rOtuLi stimulates lipid droplet biogenesis (an inflammatory marker) and induces IL-6
and TNF-α secretion in peritoneal macrophages, both proinflammatory cytokines. Our
findings suggest that OtuLi is a cytoplasmic enzyme with K48-linked substrate specificity
that could play a part in proinflammatory response in stimulated murine macrophages.
Keywords: leishmania, deubiquitination, cysteine protease, molecular dynamic, site-directed mutagenesis,
otubain
INTRODUCTION
Visceral leishmaniasis (VL), also known as kala-azar, is the systemic form of vector-borne disease
leishmaniasis, mostly caused by Leishmania infantum and L. donovani that affects visceral organs
and triggers general damages including hepatosplenomegaly and lymphadenopathy (Pearson and
Sousa, 1996). VL can be fatal if left untreated and, due to the associated cellular immunity
depression, predisposes to secondary infections (Choi and Lerner, 2001). Majority of VL cases
are concentrated in Africa and South America, and ∼90% of known cases in America take place
in Brazil, especially in the Northeast region (Harhay et al., 2011). Although, 200,000 cases are
estimated and∼20,000 deaths are assigned to VL (Alvar et al., 2012), the available pharmacological
intervention faces emerging resistance and severe side effects (Kobets et al., 2012).
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The establishment of Leishmania infection is dependent
upon the success of the invasion of phagocytic cells, mainly
macrophages, and dendritic cells, by promastigote forms and
the survival of amastigote forms inside the cells (reviewed in
Rodrigues et al., 2016). Subverting host’s immune response is
essential to determine the disease progression. Post-translational
modifications, such as ubiquitination, seem to be a regulator of
host-pathogen interactions through the modulation of immune
signaling (Srivastav et al., 2012).
Ubiquitination consists of the covalent binding of ubiquitin
molecules (Ub) to a protein substrate in order to regulate
signaling pathways, either taking these target proteins for
degradation by the 26S proteasome or modifying their activity
or localization (Husnjak and Dikic, 2012). Ubiquitin linking to a
substrate can be realized through any of the 7 lysines present in
the ubiquitin molecule (K6, K11, K27, K29, K33, K48, and K63)
or the N-terminal methionine residue. Depending upon linkage,
the target could fate different outcomes in the cell (Komander
and Rape, 2012). Polyubiquitinated targets on K48 represent the
vast majority in eukaryotic cells and they are directed to the 26S
proteasome for degradation (Hershko and Ciechanover, 1998).
Polyubiquitinated chains on K63 are involved in several non-
degradative cellular processes such as DNA repair (Doil et al.,
2009; Stewart et al., 2009), gene transcription (Wang et al., 2001;
Xu et al., 2009), and innate immune responses (Gack et al., 2007).
Insights concerning the role of polyubiquitination on other
lysines is still advancing (reviewed in Swatek and Komander,
2016; Yau and Rape, 2016).
This post-translational modification can be reversed by
the deconjugation of the Ub molecule or chain by specialized
proteases called deubiquitinating enzymes (DUBs) capable of
regenerating free ubiquitin molecules. DUBs play an important
role in the regulation of various processes, such as tumor
progression, immune regulation, and neurodegeneration
(Nijman et al., 2005). DUBs can be divided into five families,
from which 4 are cysteine-proteases: ubiquitin carboxyl-terminal
hydrolase (UCHs), ubiquitin-specific protease (USPs), ovarian
tumor-related proteases (OTUs), Machado-Joseph disease
proteases (MJDs), and one JAB1/MPN/MOV34metallo-protease
(JAMMs) (Komander et al., 2009). These enzymes have a
substrate specificity that is conferred by their protein interaction
domains, the nature of the ubiquitin chain linkage and their
subcellular localization (Wertz et al., 2004; Nijman et al., 2005;
Kayagaki et al., 2007).
Otubain is a protease family member related to OTUs, the
second largest DUB family in mammals, first described in
Drosophila melanogaster (King and Storto, 1988) and related
to the regulation of T cell anergy by interacting with the E3
ligase GRAIL promoting activation of T cells in mice (Soares
et al., 2004). Proteases containing the OTU domain seem to
have appeared in eukaryotes’ evolution by acquisition from
intracellular pathogens, indicating that the presence of these
proteases may be related to host-pathogen interaction (Makarova
et al., 2000). The Chlamydia caviae OTU (ChlaOTU) has
deubiquitinating activity and proved to be an effector type III
secretion protein. ChlaOTU is able to deubiquitinate proteins
on the entrance site of C. caviae into the cell and also binds to
NDP52, a host protein important to the invasion and to bacterial
growth inside the host cell (Furtado et al., 2013). Regarding
parasites, the first active DUBs were identified in Plasmodium
falciparum (Artavanis-Tsakonas et al., 2006) and Toxoplasma
gondii (Frickel et al., 2007). Transcriptional analyses of MJD
and OTU transcripts from Schistosoma mansoni demonstrated
differential regulation throughout the parasite cycle (Pereira
et al., 2015). Genetic analyses showed that the parasite P.
chabaudi resistant to chloroquine and artesunate have a mutation
in a DUB (Hunt et al., 2007). Otubain from Cryptosporidium
parvum (CpOTU) has been characterized showing that it is more
expressed in the oocyst stage of the parasite (Ju et al., 2014).
Since OTU family enzymes seem to be involved in
the regulation of different cellular processes, including
immunological pathways regulation, and considering that
the establishment of Leishmania in its host depends on host
immune response modulation, it seems promising to investigate
the relevance of deubiquitination in Leishmania infection. In this
work, we first characterized an otubain-like enzyme presented
in the cytoplasm of L. infantum promastigotes with preferential
K48-linked deubiquitinating activity in vitro. In this sense, we
generated three recombinant OtuLi variants carrying point
mutations on OTU domain and on a hydrophobic surface
important for interaction with ubiquitin residues (Nanao et al.,
2004). We showed that recombinant OtuLi cleaves K48-linked
tetra-ubiquitin and the F82 besides the catalytic C81 seems
critical to its enzymatic activity. K63-linked tetra-ubiquitin is
also substrate for rOtuLi, although such activity is less expressive
and completely abolished when a single amino acid present in
the Ub-interaction motif is changed (F182). Altogether, these
results compose the first study concerning the deubiquitinating
enzymes in Leishmania and represent a prelude in order to
understand the deubiquitination process in kinetoplastids.
MATERIALS AND METHODS
Parasites
L. infantum promastigotes were maintained in Schneider’s Insect
medium (Sigma Aldrich) supplemented with 20% (v/v) heat-
inactivated fetal bovine serum (FBS) and 100 µg/mL gentamycin
sulfate at 28◦C.
Recombinant OtuLi Expression in E. coli
Plasmids (pET19-b) containing the WT otuli or the sequence
carrying the site-directed mutations that generated the F182S,
F182S/L265P, and F82S/F182S/L265P variants (T545C,
T545C/T794C, and T245C/T545C/T794C as nucleotide
sequence respectively) were synthesized by GenScript©. The
constructions were expressed in BL21 (DE3) E. coli and produced
the C-terminal His-tagged OtuLi under induction by 0.1 mM
IPTG at 18◦C for 5 or 16 h (F82S/F182S/L265P variant). The
cells were lysed with BugBusterTM (Merck) and the supernatant
was applied into the His-Bind R© column (Novagen), washed with
increasing concentration of imidazole and harvested with elution
buffer (500mM NaCl, 20mM Tris-HCl, 200mM imidazole, pH
7.5). After enzyme purification, WT rOtuLi and the 3 variants
were dialyzed and concentrated with 25mM Tris-HCl, pH
Frontiers in Chemistry | www.frontiersin.org 2 March 2017 | Volume 5 | Article 13
Azevedo et al. Otubain from L. infantum
7.5. Purified enzymes was stored in 50% glycerol at −20◦C
and analyzed by SDS/PAGE (12% polyacrylamide gel) under
reducing conditions with coomassie blue or silver staining.
Antibody Production
The purified WT rOtuLi (5 µg) in Freund’s complete adjuvant
was used to immunize male BALB/c mice, followed by
three biweekly immunizations in Freund’s incomplete adjuvant.
Immune sera were collected 5 days after the last immunization,
diluted in glycerol (1:1) and analyzed by western blotting to
evaluate the specific antibody production against the protein
extract from L. infantum and the purified recombinant protein.
Western Blotting Analysis
L. infantum promastigotes previously washed with PBS were
submitted to the freezing/thawing process repeatedly in order
to lyse cells and to obtain the soluble (SE) and insoluble (IE)
protein extract. The proteins were transferred to a nitrocellulose
membrane, blocked for unspecific antibody’s interactions with
TBS containing 5%milk followed by anti-OtuLi antibody (1:100)
incubation and goat anti-mouse IgG horseradish peroxidase
conjugated (1:30,000). Blotting analyses were developed using
the ECLTM Prime Western blotting detection reagent (GE
Healthcare) and performed in ImageQuant LAS 4,000 (GE
HealthCare).
Recombinant OtuLi Deubiquitination and
Inhibition Assays
The enzyme reaction was performed with 250 ng of rOtuLi and
250 ng of K48- or K63-linked tetra-ubiquitin in 25mM Tris pH
7.5 or 25mMMES pH 5.5 for 5 h. For inhibition profile, 100 µM
N-Ethylmaleimide (NEM) and 100 µM trans-Epoxysuccinyl-
L-leucylamido(4-guanidino)butane (E-64) were incubated with
rOtuLi for 30min before addition of tetra-ubiquitin. Reactions
were interrupted by addition of sample buffer (62.5 mM Tris–
HCl pH 6.8, 2% m/v SDS, 5% v/v β-mercaptoethanol, 0.08% m/v
bromophenol blue and 30% v/v glycerol) and analyzed by 12%
SDS/PAGE, followed by silver staining.
Homology Modeling
The search for template was made in PDB—Protein Data Bank
(www.rcsb.org/pdb) and the crystal structure of human otubain
(2ZFY) (Edelmann et al., 2009) was chosen. The alignment of the
target sequence (OtuLi) with the template (HsOtu1) was made
using the T-Coffee software resulting in 32% identity and 44%
similarity. Then, a model was constructed using the Swiss Model
Server and the structural figures were generated with PyMOL
system. The OtuLi model was validated using PROCHECK
software (Laskowski et al., 1996).
Molecular Dynamics
The simulated ensembles are comprised of the macromolecule
otubain from L. infantum, in both WT and inactive
(F82S/F182S/L265P) forms, immersed in TIP3P water molecules
(Berendsen et al., 1981). For each conformation, all-atom
models of the non-bonded conformation and the OtuLi-
Ubiquitin complex were constructed in GROMACS 4.6.7
using the CHARMM22 force field (Lazaridis and Karplus,
1999; Brooks et al., 2009; Pronk et al., 2013). Each protein was
amidated at its C-terminus. All four different conformations
were contained using periodic boundary conditions with unit
cells corresponding to dodecahedral boxes with dimensions
that enable adequate sampling without added complications
arising from the proteins directly interacting with their mirror
images. The four systems were then individually solvated with
TIP3P water (wild non-bonded: 8,365 molecules TIP3P; wild
OtuLi-Ubiquitin complex: 19,117 molecules TIP3P; Inactive
non-bonded: 8,208 molecules TIP3P; inactive OtuLi-Ubiquitin
complex: 20,124 molecules TIP3P), and salt ions were added
to achieve electro-neutrality at a final salt concentration of
1.5M. After generating the solvated structures, the system was
energy minimized using steepest descent until the change in
potential energy between time-steps converged to machine
precision. After energy minimization, the system underwent two
phases of equilibration by using the Berendsen pressure and
temperature coupling methods; it was first equilibrated with a
time-step of 2 fs for 10 ps under constant pressure, and then was
equilibrated with a time-step of 2 fs for 10 ps under constant
pressure (Berendsen et al., 1984). Finally, the system underwent
a 2 ns simulation of position restraint, in which the protein was
restrained and the solvent molecules were relaxed through an
energy minimization step under constant temperature by using
the Berendsen temperature coupling method. All simulations
were run under constant pressure and temperature (NPT). We
performed a total of 200 ns of molecular dynamics simulations
to sample the largest possible conformational space. During the
production runs, the LINCS algorithm was used to constrain
the lengths of bonds involving Hydrogen atoms, which vibrate
faster than our simulation time-step of 2 fs (Hess et al., 1997),
and the SETTLE algorithm was used to constrain the bond
lengths within water molecules (Miyamoto and Kollman, 1992).
Electrostatic calculations were performed using the Particle
Mesh Ewald (PME) method with a cut-off radius of 1.4 nm
(Darden et al., 1993). The same radius value cut-off was also used
in the van der Waals calculations. The non-bonded list of each
atom was updated every 10 simulation-steps. All simulations
were performed using GROMACS 4.6.7 with the CHARMM22
force field with a machine temperature of 300 K.
In vitro Stimulation of Peritoneal
Macrophages by rOtuLi
Murine peritoneal macrophages (106 cells/mL) from six C57BL/6
mice were harvested by peritoneal lavage and adhered for 16 h
in RPMI medium supplemented with 2% FBS and non-adherent
macrophages were removed by washing with PBS. Cells were
stimulated with 1 µg of rOtuLi or the boiled denatured enzyme
for 24 and 48 h at 37◦C and 5% CO2 atmosphere.
Lipid Droplet Biogenesis Analysis
Peritoneal macrophages seeded in 24-well plate coverslips
stimulated or not with rOtuLi were fixed in 3.7% (v/v)
formaldehyde diluted in PBS. Then, the coverslips were washed
three times with ultrapure water and incubated with Propylene
Glycol (PEG) for 15min. Subsequently, the coverslips were
Frontiers in Chemistry | www.frontiersin.org 3 March 2017 | Volume 5 | Article 13
Azevedo et al. Otubain from L. infantum
incubated with 0.5% Oil Red for 30min and with 60% PEG for
1min. After three washes, cells were stained with hematoxylin
solution for 5 s. Finally, the slides were mounted with Aqua
Poly/Mount medium (Vector). Lipid droplet biogenesis was
assessed by quantification of lipid droplet structures on 50
consecutive cells by bright field microscopy.
Quantification of Cytokines
The supernatants of the peritoneal macrophages stimulation
assay with rOtuLi were collected at 24 and 48 h.
IL-6 and TNF-α cytokines were measured by ELISA,
using a commercial kit (eBioscience). The assay was
performed following manufacturer’s instructions and
cytokine levels were demonstrated in absolute values
(pg/mL).
Fluorescence Microscopy
For mitochondrion labeling, L. infantum promastigotes were
washed with PBS, incubated in 80 nM MitoTracker Red
CMXRos (Molecular Probes) for 1 h. Then, parasites were
washed with PBS and immunofluorescence assay was conducted
by fixing them with 3.7% paraformaldehyde with subsequent
FIGURE 1 | Alignment of otubain sequences from different organisms. Amino acid sequences available at NCBI from Leishmania infantum (XP_001464809.1),
L. donovani (CBZ33300.1), L. mexicana (XP_003874007.1), L. major (CAJ04142.1), L. braziliensis (XP_001563920.1), L. panamensis (AIN97175.1), Trypanosoma
cruzi (XP_816450.1), otubain-1 from Homo sapiens (NP_060140.2) and otubain-2 from H. sapiens (NP_075601.1) were aligned using the T-Coffee software. Lines
represent the extended N-terminal from HsOtu1 (black), the OTU domain (purple) and the ubiquitin-interaction motif (orange). The green triangles correspond to the
catalytic triad. The conserved amino acids chosen to be replaced are F82 (yellow), F182 (blue), and L265 (red).
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permeabilization with 0.1% Triton X-100 and then spread
onto a poly-L-lysine coated glass slide. For OtuLi labeling,
parasites were incubated with the primary antibody anti-OtuLi
(1:100) for 2 h. For PDI labeling, an anti-PDI antibody from
Gallus gallus was used in a 1:500 dilution for 2 h. After washing
with PBS, parasites were incubated with one of the following
antibodies: goat anti–mouse IgG conjugated with Alexa Fluor
488 (1:500) for OtuLi labeling, goat anti-rabbit IgG conjugated
with Alexa Fluor 568 (1:300) for PDI labeling both for 2 h.
For DNA staining, 100 ng/mL DAPI were used for 10 min
and the slides were mounted with ProLong R© Gold antifade
(Invitrogen) and observed under a Nikon Eclipse TE 300 DV
inverted microscope using appropriate fluorescence emission
filters at room temperature. Data acquisition and processing
were performed with MetaMorph and ImageJ software,
respectively.
FIGURE 2 | Expression of OtuLi in bacteria and identification of the native enzyme in promastigote forms. (A) Expression of the recombinant enzymes in
E. coli BL21 (DE3) in soluble or insoluble extracts was compared to the expression of empty pET-19b (−) analyzed by coomassie blue staining. (B) Purification of the
WT rOtuLi and its variants by nickel affinity chromatography. Non-bounded proteins (NB), wash fractions obtained with increasing concentration of imidazole and
elution with 200 mM (or 400 mM for F82S/F182S/L265P variant) imidazole were analyzed by coomassie blue staining. (C) Confirmation of OtuLi in soluble extract (SE)
from promastigote forms by western blotting.
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FIGURE 3 | Enzymatic activity characterization of rOtuLi. (A) Enzymatic activity of rOtuLi against K48-4Ub or K63-4Ub substrates in 25 mM Tris pH 7.5. (B)
Inhibition of rOtuLi in the presence of classic inhibitors in 25 mM Tris pH 7.5. (C) Enzymatic activity of rOtuLi with K48-4Ub in 25 mM MES pH 6.5. All reactions were
carried out for 5 h at 25◦C, stopped by adding sample buffer and analyzed by silver staining.
Ethics Statement
This study was carried out in accordance with institutional
guidelines. The protocol was approved by Comissão de Ética de
Uso Animal from the University of Brasilia, No. 27764/2016.
Statistical Analysis
The graphics were generated using the Software GraphPad Prism.
The results of lipid bodies and cytokines quantification were
expressed as mean ± standard error of the mean (SEM) and
statistically analyzed with analysis of variance (ANOVA) followed
by t-Student test. The p significance level was broken down in the
results.
RESULTS
OtuLi Sequence Analyses and Expression
Pattern
Analysis of the L. infantum genome was performed using the
Database of Ubiquitinating and Deubiquitinating Enzymes
(http://www.DUDE-db.org/) (Hutchins et al., 2013), and
provided 27 predicted proteins of which 16 are from the USP
family, 5 from the JAMM family, 4 from the OTU family,
and 2 from the UCH family. There were no predicted genes
coding to proteases belonging to the MJD family. The otubain
cysteine peptidase herein named OtuLi (XP_001464809.1)
was selected among the predicted OTU enzymes for further
characterization based on its low amino acids identity compared
to the human otubain-1 (33%; AAO27702.1) and otubain-2
(26%; AAO27703.1).
The otuli gene has an open reading frame of 813 bp that
codifies a protein of 270 amino acids corresponding to a
predicted molecular weight of 30.3 kDa. The catalytic triad
consists of the Cys81, His261, and Asn263 residues with an
ubiquitin interaction motif (UIM) preserved. The ubiquitin-
associated (UBA) domain and the nuclear localization signal
which are commonly conserved in OTU family proteins and an
extended N-terminal present in HsOtu1 are absent (Figure 1).
Otubain is conserved between the subgenus Leishmania, mainly
FIGURE 4 | Evaluation of the molecular models from OtuLi and its
variants. The three-dimensional models of WT OtuLi (A) and the overlapped
models of F182S (B), F182S/L265P (C), and F82S/F182S/L265P (D) with WT
OtuLi. WT OtuLi (pink) and its variants (magenta) models show the catalytic
triad (C81, H261, and N263) in green and the amino acids F82S (yellow),
F182S (blue), and L265P (red). (E) Enzymatic activity of the variants against
K48- or K63-4Ub in 25 mM Tris pH 7.5.
with L. donovani (99%) and L. major (98%). Regarding its
counterpart in Trypanosoma cruzi, OtuLi shows only 39%
identity.
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Prior the enzymatic characterization of OtuLi, we obtained
its recombinant enzyme (rOtuLi) by expression in prokaryotic
system using vector pET19-b, which fused the enzyme to a
histidine tail used for nickel-agarose purification. In order
to better understand the catalytic mechanism, site-directed
mutations were introduced into otuli sequence generating
a single (F182S), a double (F182S/L265P), and a triple
(F82S/F182S/L265P) variant. Thesemutations affected conserved
amino acids that are located next to the Cys residue from
the active site (F82), inside OTU domain (L265), or part of
a hydrophobic surface (F182) important to the interaction
with the ubiquitin molecule (Nanao et al., 2004). Variants
were also obtained in prokaryotic system using the same
expression vector. WT OtuLi, F182S and F182S/L265P variants
were produced in abundance as both soluble and insoluble
forms in BL21 (DE3) E. coli. However, the F82S/F182S/L265P
variant was produced in small amount as soluble enzyme
(Figure 2A). Nevertheless, WT and the 3 variants were
successfully obtained as purified enzymes and used to perform
enzymatic assays (Figure 2B). Native OtuLi was identified in
soluble extract from promastigote forms of L. infantum using
the polyclonal antibody against theWT rOtuLi produced in mice
(Figure 2C).
Enzymatic Activity and Comparative
Molecular Modeling of WT OtuLi and
Variants
The deubiquitinating activity was assessed by rOtuLi capability
of cleaving K48- and K63-linked tetra-ubiquitin (4Ub) substrates
at pH 7.5. rOtuLi cleaves preferentially K48-4Ub over K63-
4Ub, as indicated by the complete cleavage to monoubiquitin
(1Ub) in the K48-4Ub reaction and the partial activity of
OtuLi against K63-4Ub with hydrolysis to tri-ubiquitin and di-
ubiquitin (Figure 3A). Enzymatic activity was also assessed with
fluorescent substrates such as Ub-AMC and Z-LRGG-AMC but
rOtuLi was inactive (data not shown).
Considering the rOtuLi specifity for K48-4Ub, the inhibition
pattern of the enzyme was assessed with this same substrate.
Being OtuLi classified as a cysteine peptidase, the standard
cysteine peptidase inhibitors E-64 and NEM were tested.
Surprisingly, rOtuLi was not inhibited by E-64 and inhibited
in a moderate manner by NEM, as we could see an intense
band corresponding to 3Ub (Figure 3B). We also assessed the
enzymatic activity in acidic environment and rOtuLi remained
active at pH 5.5 (Figure 3C).
According to the homology modeling, the OtuLi model
comprises 10 α-helixes and 4 β-strands that altogether constitute
FIGURE 5 | Interaction between OtuLi and ubiquitin. Simulated ensembles of OtuLi and an ubiquitin molecule, using WT enzyme (A) and F82S/F182S/L265P
variant (B). Amino acids mobility in WT OtuLi (A, bottom) and F82S/F182S/L265P OtuLi (B, bottom) models considering their free (black) and Ub-complexed (red)
forms.
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the β-sheet responsible for stabilizing the core of the protein.
This portion provides the catalytic triad formed by C81, H261,
and N263 residues (Figure 4A). There were significant changes
between the WT OtuLi and the variants’ models, mostly
with F82S/F182S/L265P as shown by the overlapped models
(Figures 4B–D) and by the RMSD values. Comparing the RMSD
values, it was observed a difference of 1,512 Å (WT and F182S),
1,690 Å (WT and F182S/L265P), whereas the main difference
(2,484 Å) was between WT and F82S/F182S/L265P. The F182S
variant remains active against K48-linked substrate. However,
the addition of L265P mutation (F182S/L265P) abolishes the
enzyme activity against K48-4Ub, since no cleavage was seen with
this mutant (Figure 4E, left). Regarding the enzymatic activity
against K63-4Ub substrate, the F182S mutation was enough to
confer inactivity to OtuLi (Figure 4E, right), implying that F182
residue is crucial to OtuLi activity against K63-linked substrates.
Molecular dynamics simulations of the OtuLi-Ub complex
showed an elevated degree of flexibility for some residues from
theWT enzyme when compared to its free form. This flexibility is
observed when we compare the root mean square fluctuation per
residue of both the free and complex forms. Moreover, the same
was not observed on F82S/F182S/L265P variant and Ub complex
simulation (Figure 5). This lack of flexibility may explain the
large amount of inclusion bodies observed on F82S/F182S/L265P
variant produced in bacteria (Figure 2A), besides its inactivity
against both substrates (data not shown).
OtuLi Is a Cytoplasmic Enzyme and
Induces an Inflammatory Response In vitro
In order to investigate the localization of OtuLi in promastigotes,
a mitochondrion probe, or the Protein Disulfide-Isomerase
(PDI) antibody (Florent et al., 2000) were employed to label
mitochondrion and endoplasmic reticulum, respectively. OtuLi
is presented in small vesicles along the cytoplasm of the
cell, although an intense fluorescence can be observed near
kinetoplast. There was no co-localization with mitochondrion
or PDI (Figure 6). To examine whether rOtuLi could have an
immunomodulatory effect, murine peritoneal macrophages were
incubated with the enzyme and analyzed after 24 and 48 h of
stimulation. rOtuLi triggered prominent lipid droplet biogenesis
(a structural marker of inflammation) in macrophages compared
both to unstimulated cells and macrophages stimulated with
denatured rOtuLi, which presented three-fold less amount
of lipid droplet after 48 h (Figure 7A). In addition, rOtuLi
was able of triggering significant TNF-α and IL-6 secretion
in macrophages compared to unstimulated cells after 24 h
(Figure 7B).
DISCUSSION
Here we paved the way for further studies about deubiquitination
in trypanosomatids, especially Leishmania, by characterizing the
otubain-like enzyme from L. infantum. Considering biochemical
aspects, rOtuLi was able to cleave both K48- and K63-linked
substrates, although its enzymatic activity is less pronounced on
the last one. Otubains are classified as cysteine proteases and
FIGURE 6 | OtuLi cellular localization. Cytolocalization of OtuLi,
mitochondrion probed with Mitotracker Orange (A) and PDI (B). Genomic
DNA and kinetoplast (blue) were labeled by DAPI. Bars: 5 µm.
rOtuLi was inhibited by NEM, however the described otubain
from C. parvum (CpOTU) (Ju et al., 2014) and rOtuLi showed
activity with E-64, a well-defined inhibitor for cysteine proteases.
Whereas, the majority of cysteine proteases have optimal activity
in acidic pH (Turk et al., 1995), it was investigated whether
rOtuLi was active at pH 5.5. In fact, rOtuLi is active in more
acidic pH in a similar manner to the activity at neutral pH,
unlike CpOTU that showed instability in acid pH and its optimal
enzymatic activity is at pH 7.5 (Ju et al., 2014).
The HsOtu1 and HsOtu2 structures reveal that the active site
is formed by an α-helix and β-sheet lobes centering the catalytic
C91/H265/D267 or C51/H224/N226, respectively, where the
conformation of H265 in HsOtu1 and its distance to the C91
and D267 is incompatible with catalysis indicating a singularity
face to other cysteine proteases (Edelmann et al., 2009). This
steric incompatibility of the catalytic site seems to be reversed
with the structural rearrangement of the molecule when the
ubiquitin binds to the ubiquitin interaction motif, also present
in OtuLi, which leads to Ub chain cleavage. In fact, as shown by
our molecular dynamics assays, the substrate seems to play an
important role over themobility of specific amino acids, therefore
contributing to the WT OtuLi structure rearrangement for
proper substrate accommodation in the catalytic pocket, which
was not observed in the inactive F82S/F182S/L265P variant.
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FIGURE 7 | Immunomodulatory profile of rOtuLi in murine macrophages. (A) Peritoneal macrophages from C57BL/6 mice incubated with boiled rOtuLi
(denOtuLi/boiled Otu) or rOtuLi (Otu) for 24 and 48 h were observed by light microscopy at 50 cells separately. Original magnification × 100 (**p < 0.01, ****p <
0.0001). (B) Cytokine production from stimulated or unstimulated (Uns) macrophages for TNF-α and IL-6 production levels were assessed by ELISA (**p < 0.01, ****p
< 0.0001).
Furthermore, considering the sequence analysis, the lack of an
N-terminal extension allows the interaction with ubiquitin in a
more permissive way, which could explain the fact that rOtuLi
cleaves both ubiquitin chains connected to K48 and K63, as well
as HsOtu2 (Altun et al., 2015). However, this flexibility was not
sufficient for enabling the cleavage of Ub-AMC by rOtuLi while
HsOtu2 is capable of cleaving Ub-AMC because the AMC can
be properly accommodated in the catalytic pocket where G47
seems to be relevant for this process (Edelmann et al., 2009). In
rOtuLi the correspondent residue is R77 and P87 in HsOtu1 (also
unable to cleave Ub-AMC) that promotes a steric hindrance in
the catalytic core that compromises both interaction and cleavage
of this substrate (Edelmann et al., 2009).
To describe the role of critical amino acids, three different
variants carrying point mutations were also studied. The F182
residue in OtuLi is a conserved amino acid and is present in
a hydrophobic surface of HsOtu2 which is exposed and form
a pocket for interaction with ubiquitin residues (Nanao et al.,
2004). Thus, the purpose was to evaluate if the switch of the F182
for a hydrophilic amino acid (S182) would impair enzymatic
activity, but it was not enough to cause the loss of OtuLi activity
against K48-4Ub, although F182 seems to be important to the
cleavage of K63-4Ub once it was not possible to detect activity
with this latter substrate. Upon the introduction of a bulky
amino acid (P265) next to a conserved residue, part of the OTU
domain, the enzyme completely loses its activity against K48-
4Ub, which indicates that L265 is a critical amino acid for the
catalysis of K48-linked substrates. It is not possible to claim that
the insertion of a third mutation (F82S) beside the catalytic Cys is
responsible for the inactivity of F82S/F182S/L265P variant, since
F182S/L265P variant is intrinsically inactive, however, the third
mutation caused the formation of a large amount of inclusion
bodies with F82S/F182S/L265P OtuLi in bacteria. The formation
of inclusion bodies may be a consequence of the drastic changes
in the protein structure leading to an inefficient misfolding
caused by the coordinated action of the three mutations.
Cytolocalization assays showed that OtuLi is sorely present
in a region near kinetoplast, especially in parasites with shorter
flagellum or rounded-shape cell bodies. It was previously shown
that otubain gene in L. infantum is differentially regulated after
generation of axenic amastigote forms treated at pH 4.5, being
1.8-fold upregulated in these forms (Alcolea et al., 2010), indeed,
the cellular localization of OtuLi in amastigote forms has to be
performed to assert this assumption.
Previous studies suggested intracellular accumulation of lipid
droplet in cells infected or stimulated with Leishmania (Rabhi
et al., 2016) could help triggering cytokine signal (Bozza et al.,
2007). Knowing that otubains have been implicated in the
immunological events, we aimed to investigate the role of
rOtuLi in modulation of inflammatory parameters of murine
macrophages. Our data suggest that rOtuLi is capable of
modulating immune and inflammatory response in murine
peritoneal macrophages, since this enzyme induced lipid droplet
biogenesis, an important intracellular marker of inflammation,
as well as IL-6 and TNF-α secretion, two proinflammatory
cytokines. However, the question whether OtuLi can be secreted
by the parasite when it is inside the phagolysosome remains
unanswered and needs to be further addressed. The sequence
analyses of OtuLi did not show a peptide signal, but this enzyme
could be secreted by non-classical routes, such as exocytosis of
lysosomal compartment (McConville et al., 2002).
In summary, we identified a novel otubain-like from L.
infantum with deubiquitinating activity located along the
cytoplasm from promastigote forms and our results suggest that
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this enzyme could trigger inflammatory response in vitro. This
study was also relevant to initiate future studies to elucidate the
functional role of deubiquitinating enzymes with the intention to
describe the deubiquitination process and address its importance
in the establishment of infection by these parasites.
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